The Food and Drug Administration (FDA) through the Center for Device Regulation, Radiation Health and Research (CDRRHR) has finalized the draft Administrative Order entitled “Addendum to Administrative Order No. 50 s. 2001 entitled “Revised 2001 Schedule of fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs.””
In the interest of service and to seek the comments of the stakeholders that will be affected by the above-mentioned proposed policy, the FDA is inviting representatives from manufacturers, traders and distributors (importers, exporters, and wholesalers) of health-related devices such as equipment or devices used for treating sharps, pathological and infectious wastes, and water treatment devices/systems, to attend the Virtual Public Hearing on 21 December 2022 at 10:00 A.M. via Microsoft Teams. Eighty (80) slots have been allotted for those interested to attend the said activity. One (1) representative per company shall be accommodated.
To register and confirm your attendance, kindly accomplish the registration form through this link: